What is Nuubo?
Nuubo operates at the intersection of textile engineering and medical diagnostics, providing a disruptive approach to long-term cardiac monitoring. The company's core innovation lies in its textile electrode technology, which facilitates high-fidelity ECG signal acquisition without the discomfort associated with traditional Holter monitors. By prioritizing patient compliance through a seamless, wearable form factor, Nuubo enables healthcare providers to obtain high-quality, longitudinal data that is critical for the early detection and management of cardiac arrhythmias.
The company's market position is defined by its ability to transform complex clinical monitoring into a user-friendly experience. As healthcare systems globally shift toward decentralized care models, Nuubo's technology offers a robust solution for remote patient monitoring, ensuring that clinicians have access to reliable, actionable insights while patients maintain their daily routines. This focus on both clinical efficacy and patient experience distinguishes Nuubo from legacy diagnostic hardware manufacturers.
How much funding has Nuubo raised?
Nuubo has raised a total of $4M across 1 funding round:
Unspecified
$4M
Unspecified (2014): $4M with participation from Fides Capital and CRB Inverbu00edo
Key Investors in Nuubo
Fides Capital
FIDES Capital Partners is a Real Estate Advisory and Investment firm that provides tailored solutions to real estate owners, investors, lenders, and investment partners.
CRB Inverbio
CRB Inverbio is a private venture capital management firm that specializes in life sciences, focusing on innovative early-stage startups in biotech, med tech, digital health, and medical technologies.
What's next for Nuubo?
Looking ahead, the strategic deployment of this capital will likely focus on scaling manufacturing capabilities and deepening clinical validation studies to support broader adoption in hospital and outpatient settings. As the demand for remote diagnostic tools continues to rise, Nuubo is poised to leverage its technological foundation to integrate with broader digital health ecosystems. The company's roadmap suggests a transition toward more sophisticated data analytics, potentially incorporating machine learning to enhance the predictive capabilities of its monitoring systems. By maintaining its focus on high-compliance, non-invasive solutions, Nuubo is set to remain a key player in the evolution of cardiovascular care, driving efficiency and improved outcomes for both providers and patients alike.
See full Nuubo company page
